LightWave Acquisition (LWAC) Competitors

$10.18 0.00 (0.00%)

Closing price 03:59 PM Eastern

Extended Trading

$10.18 0.00 (-0.05%)

As of 04:10 PM Eastern

LWAC vs. CALT, AVTE, SBTX, WHWK, and CNTN

Should you be buying LightWave Acquisition stock or one of its competitors? The main competitors of LightWave Acquisition include Calliditas Therapeutics AB (publ) (CALT), Aerovate Therapeutics (AVTE), Silverback Therapeutics (SBTX), Whitehawk Therapeutics (WHWK), and Hillstream Biopharma (CNTN).

How does LightWave Acquisition compare to Calliditas Therapeutics AB (publ)?

Calliditas Therapeutics AB (publ) (NASDAQ:CALT) and LightWave Acquisition (NASDAQ:LWAC) are both small-cap pharmaceutical preparations industry companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, media sentiment, dividends, analyst recommendations and profitability.

: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Calliditas Therapeutics AB (publ)
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
LightWave Acquisition
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
: LightWave Acquisition has a net margin of 0.00% compared to Calliditas Therapeutics AB (publ)'s net margin of -30.18%. LightWave Acquisition's return on equity of 0.00% beat Calliditas Therapeutics AB (publ)'s return on equity.
Company Net Margins Return on Equity Return on Assets
Calliditas Therapeutics AB (publ) -30.18% -212.04% -27.96%
LightWave Acquisition N/A N/A N/A
: In the previous week, Calliditas Therapeutics AB (publ)'s average media sentiment score of 0.00 equaled LightWave Acquisition'saverage media sentiment score.
Company Overall Sentiment
Calliditas Therapeutics AB (publ) Neutral
LightWave Acquisition Neutral
: LightWave Acquisition has lower revenue, but higher earnings than Calliditas Therapeutics AB (publ).
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Calliditas Therapeutics AB (publ) $1.60B 0.74 -$43.96M -$1.85 N/A
LightWave Acquisition N/A N/A N/A N/A N/A
: 2.8% of Calliditas Therapeutics AB (publ) shares are held by institutional investors. 2.2% of Calliditas Therapeutics AB (publ) shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Calliditas Therapeutics AB (publ)	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
LightWave Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Net Margins	Return on Equity	Return on Assets
Calliditas Therapeutics AB (publ)	-30.18%	-212.04%	-27.96%
LightWave Acquisition	N/A	N/A	N/A

Company	Overall Sentiment
Calliditas Therapeutics AB (publ)	Neutral
LightWave Acquisition	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Calliditas Therapeutics AB (publ)	$1.60B	0.74	-$43.96M	-$1.85	N/A
LightWave Acquisition	N/A	N/A	N/A	N/A	N/A

Summary

LightWave Acquisition beats Calliditas Therapeutics AB (publ) on 4 of the 7 factors compared between the two stocks.

How does LightWave Acquisition compare to Aerovate Therapeutics?

Aerovate Therapeutics (NASDAQ:AVTE) and LightWave Acquisition (NASDAQ:LWAC) are both small-cap pharmaceutical preparations industry companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, media sentiment, dividends, analyst recommendations and profitability.

: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Aerovate Therapeutics N/A N/A -$75.52M -$1.70 N/A
LightWave Acquisition N/A N/A N/A N/A N/A
: In the previous week, Aerovate Therapeutics had 1 more articles in the media than LightWave Acquisition. MarketBeat recorded 1 mentions for Aerovate Therapeutics and 0 mentions for LightWave Acquisition. Aerovate Therapeutics' average media sentiment score of 0.75 beat LightWave Acquisition's score of 0.00 indicating that Aerovate Therapeutics is being referred to more favorably in the media.
Company Overall Sentiment
Aerovate Therapeutics Positive
LightWave Acquisition Neutral
: LightWave Acquisition's return on equity of 0.00% beat Aerovate Therapeutics' return on equity.
Company Net Margins Return on Equity Return on Assets
Aerovate Therapeutics N/A -90.19% -77.47%
LightWave Acquisition N/A N/A N/A
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aerovate Therapeutics
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
LightWave Acquisition
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aerovate Therapeutics	N/A	N/A	-$75.52M	-$1.70	N/A
LightWave Acquisition	N/A	N/A	N/A	N/A	N/A

Company	Overall Sentiment
Aerovate Therapeutics	Positive
LightWave Acquisition	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Aerovate Therapeutics	N/A	-90.19%	-77.47%
LightWave Acquisition	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aerovate Therapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
LightWave Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

LightWave Acquisition beats Aerovate Therapeutics on 3 of the 5 factors compared between the two stocks.

How does LightWave Acquisition compare to Silverback Therapeutics?

Silverback Therapeutics (NASDAQ:SBTX) and LightWave Acquisition (NASDAQ:LWAC) are both small-cap pharmaceutical preparations industry companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, media sentiment, analyst recommendations, dividends and profitability.

: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Silverback Therapeutics N/A N/A -$89.48M -$2.42 N/A
LightWave Acquisition N/A N/A N/A N/A N/A
: 74.9% of Silverback Therapeutics shares are held by institutional investors. 34.4% of Silverback Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
: In the previous week, Silverback Therapeutics' average media sentiment score of 0.00 equaled LightWave Acquisition'saverage media sentiment score.
Company Overall Sentiment
Silverback Therapeutics Neutral
LightWave Acquisition Neutral
: LightWave Acquisition's return on equity of 0.00% beat Silverback Therapeutics' return on equity.
Company Net Margins Return on Equity Return on Assets
Silverback Therapeutics N/A -29.62% -28.20%
LightWave Acquisition N/A N/A N/A
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Silverback Therapeutics
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
LightWave Acquisition
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Silverback Therapeutics	N/A	N/A	-$89.48M	-$2.42	N/A
LightWave Acquisition	N/A	N/A	N/A	N/A	N/A

Company	Overall Sentiment
Silverback Therapeutics	Neutral
LightWave Acquisition	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Silverback Therapeutics	N/A	-29.62%	-28.20%
LightWave Acquisition	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Silverback Therapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
LightWave Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

LightWave Acquisition beats Silverback Therapeutics on 3 of the 5 factors compared between the two stocks.

How does LightWave Acquisition compare to Whitehawk Therapeutics?

Whitehawk Therapeutics (NASDAQ:WHWK) and LightWave Acquisition (NASDAQ:LWAC) are both small-cap pharmaceutical preparations industry companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, media sentiment, analyst recommendations, dividends and profitability.

: LightWave Acquisition has lower revenue, but higher earnings than Whitehawk Therapeutics.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Whitehawk Therapeutics $7.14M 29.15 -$20.60M $0.47 8.96
LightWave Acquisition N/A N/A N/A N/A N/A
: 52.1% of Whitehawk Therapeutics shares are held by institutional investors. 49.9% of Whitehawk Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
: In the previous week, Whitehawk Therapeutics had 2 more articles in the media than LightWave Acquisition. MarketBeat recorded 2 mentions for Whitehawk Therapeutics and 0 mentions for LightWave Acquisition. Whitehawk Therapeutics' average media sentiment score of 1.16 beat LightWave Acquisition's score of 0.00 indicating that Whitehawk Therapeutics is being referred to more favorably in the media.
Company Overall Sentiment
Whitehawk Therapeutics Positive
LightWave Acquisition Neutral
: LightWave Acquisition's return on equity of 0.00% beat Whitehawk Therapeutics' return on equity.
Company Net Margins Return on Equity Return on Assets
Whitehawk Therapeutics N/A -62.88% -58.98%
LightWave Acquisition N/A N/A N/A
: Whitehawk Therapeutics presently has a consensus target price of $7.00, suggesting a potential upside of 66.27%. Given Whitehawk Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Whitehawk Therapeutics is more favorable than LightWave Acquisition.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Whitehawk Therapeutics
1 Sell rating(s)
1 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.50
LightWave Acquisition
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Whitehawk Therapeutics	$7.14M	29.15	-$20.60M	$0.47	8.96
LightWave Acquisition	N/A	N/A	N/A	N/A	N/A

Company	Overall Sentiment
Whitehawk Therapeutics	Positive
LightWave Acquisition	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Whitehawk Therapeutics	N/A	-62.88%	-58.98%
LightWave Acquisition	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Whitehawk Therapeutics	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
LightWave Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Whitehawk Therapeutics beats LightWave Acquisition on 8 of the 10 factors compared between the two stocks.

How does LightWave Acquisition compare to Hillstream Biopharma?

LightWave Acquisition (NASDAQ:LWAC) and Hillstream Biopharma (NASDAQ:CNTN) are both small-cap pharmaceutical preparations industry companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings, analyst recommendations and media sentiment.

: In the previous week, LightWave Acquisition's average media sentiment score of 0.00 equaled Hillstream Biopharma'saverage media sentiment score.
Company Overall Sentiment
LightWave Acquisition Neutral
Hillstream Biopharma Neutral
: 1.2% of Hillstream Biopharma shares are owned by institutional investors. 6.7% of Hillstream Biopharma shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
: LightWave Acquisition's return on equity of 0.00% beat Hillstream Biopharma's return on equity.
Company Net Margins Return on Equity Return on Assets
LightWave Acquisition N/A N/A N/A
Hillstream Biopharma N/A -35.59% -27.05%
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
LightWave Acquisition N/A N/A N/A N/A N/A
Hillstream Biopharma N/A N/A -$35.92M -$3.99 N/A
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LightWave Acquisition
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
Hillstream Biopharma
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00

Company	Overall Sentiment
LightWave Acquisition	Neutral
Hillstream Biopharma	Neutral

Company	Net Margins	Return on Equity	Return on Assets
LightWave Acquisition	N/A	N/A	N/A
Hillstream Biopharma	N/A	-35.59%	-27.05%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LightWave Acquisition	N/A	N/A	N/A	N/A	N/A
Hillstream Biopharma	N/A	N/A	-$35.92M	-$3.99	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LightWave Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Hillstream Biopharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

LightWave Acquisition and Hillstream Biopharma tied by winning 2 of the 4 factors compared between the two stocks.

Get LightWave Acquisition News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LWAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LWAC vs. The Competition

Export

Metric	LightWave Acquisition	Pharmaceutical Preparations Industry	Sector	NASDAQ Exchange
Market Cap	$306.16M	$889.45M	$2.79B	$11.86B
Dividend Yield	N/A	4.84%	15.26%	5.21%
P/E Ratio	N/A	1.71	14.48	28.48
Price / Sales	N/A	120.50	2,089.82	60.43
Price / Cash	N/A	20.07	51.60	36.52
Price / Book	N/A	7.60	4.84	6.67
Net Income	N/A	-$4.80M	-$234.32M	$332.64M
7 Day Performance	0.05%	-0.05%	1.09%	2.01%
1 Month Performance	-0.20%	5.50%	5.42%	9.19%
1 Year Performance	N/A	30.96%	19.94%	39.59%

LightWave Acquisition Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LWAC LightWave Acquisition	N/A	$10.18 flat	N/A	N/A	$306.16M	N/A	N/A	N/A
CALT Calliditas Therapeutics AB (publ)	N/A	$40.00 flat	N/A	N/A	$1.19B	$1.60B	N/A	180
AVTE Aerovate Therapeutics	N/A	$24.23 -0.7%	N/A	N/A	$702.31M	N/A	N/A	20	High Trading Volume
SBTX Silverback Therapeutics	N/A	$8.56 +3.6%	N/A	N/A	$308.66M	N/A	N/A	83	High Trading Volume
WHWK Whitehawk Therapeutics	4.0714 of 5 stars	$3.99 -0.5%	$7.00 +75.4%	N/A	$197.22M	$7.14M	8.49	21

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LWAC) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

LightWave Acquisition (LWAC) Competitors

LWAC vs. CALT, AVTE, SBTX, WHWK, and CNTN

How does LightWave Acquisition compare to Calliditas Therapeutics AB (publ)?

Summary

How does LightWave Acquisition compare to Aerovate Therapeutics?

Summary

How does LightWave Acquisition compare to Silverback Therapeutics?

Summary

How does LightWave Acquisition compare to Whitehawk Therapeutics?

Summary

How does LightWave Acquisition compare to Hillstream Biopharma?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LWAC vs. The Competition

LightWave Acquisition Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

LightWave Acquisition (LWAC) Competitors

LWAC vs. CALT, AVTE, SBTX, WHWK, and CNTN

How does LightWave Acquisition compare to Calliditas Therapeutics AB (publ)?

Summary

How does LightWave Acquisition compare to Aerovate Therapeutics?

Summary

How does LightWave Acquisition compare to Silverback Therapeutics?

Summary

How does LightWave Acquisition compare to Whitehawk Therapeutics?

Summary

How does LightWave Acquisition compare to Hillstream Biopharma?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LWAC vs. The Competition

LightWave Acquisition Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools